Case management and supportive treatment for patients with Crimean-Congo hemorrhagic fever

Vector-Borne and Zoonotic Diseases

Volumn 12, Issue 9, 2012, Pages 805-811

  Leblebicioglu, Hakan ^a   Bodur, Hurrem ^b   Dokuzoguz, Basak ^b   Elaldi, Nazif ^c   Guner, Rahmet ^d   Koksal, Iftihar ^e   Kurt, Halil ^f   Senturk, Gonul Cicek ^g  

^a ONDOKUZ MAYIS UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c CUMHURIYET UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^d ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^e KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

^f ANKARA UNIVERSITY   (Turkey)

^g DISKAPI YILDIRIM BEYAZIT TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Blood products; Case management; Crimean Congo hemorrhagic fever

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIBIOTIC AGENT; ASPARTATE AMINOTRANSFERASE; CREATINE KINASE; FRESH FROZEN PLASMA; IMMUNOGLOBULIN; INFUSION FLUID; ISOTONIC SOLUTION; LACTATE DEHYDROGENASE; METHYLPREDNISOLONE; PARACETAMOL; PROTON PUMP INHIBITOR; RIBAVIRIN; RINGER LACTATE SOLUTION; SODIUM; THROMBOCYTE CONCENTRATE;

ACUTE RESPIRATORY FAILURE; AFRICA; APHERESIS; ARTICLE; ARTIFICIAL VENTILATION; BLOOD BANK; BLOOD CELL COUNT; BODY FLUID; CASE MANAGEMENT; CRYSTALLOID; DRUG MEGADOSE; ENDEMIC DISEASE; EPISTAXIS; ERYTHROCYTE CONCENTRATE; EUROPE; FEVER; FLUID THERAPY; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; GOOD GENERAL CONDITION; HEMATEMESIS; HEMODIALYSIS; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; INTERNATIONAL NORMALIZED RATIO; KIDNEY FAILURE; LABORATORY TEST; MELENA; MIDDLE EAST; NAIRO VIRUS; NAIROVIRUS INFECTION; NONHUMAN; OUTPATIENT CARE; PAIN; PALLIATIVE THERAPY; PARTIAL THROMBOPLASTIN TIME; PATIENT MONITORING; PLASMA TRANSFUSION; PNEUMONIA; PRIORITY JOURNAL; PROTHROMBIN TIME; SEPSIS; TERTIARY HEALTH CARE; THROMBOCYTOPENIA; TICK; TREATMENT INDICATION; TURKEY (REPUBLIC);

CASE MANAGEMENT; HEMORRHAGIC FEVER VIRUS, CRIMEAN-CONGO; HEMORRHAGIC FEVER, CRIMEAN; HUMANS;

IXODIDA;

EID: 84866281585     PISSN: 15303667     EISSN: 15577759     Source Type: Journal    
DOI: 10.1089/vbz.2011.0896     Document Type: Article

References (37)

1. Ardalan MR, Tubbs RS, Chinikar S, et al. Crimean-Congo haemorrhagic fever presenting as thrombotic microangiopathy and acute renal failure. Nephrol Dial Transplant 2006; 21:2304-2307. (Pubitemid 44295062)
2. Aydin K, Koksal I, Aksoy F, et al. The patients with Crimean-Congo Hemorrhagic Fever treated with intravenous immunoglobulin. Chicago: American Society for Microbiology, 2007:V-1908.
3. Bosly A, Muylle L, Noens L, et al. Guidelines for the transfusion of platelets. Acta Clin Belg 2007; 62:36-47. (Pubitemid 46512949)
4. British Committee for Standards in Haematology Blood Transfusion Task Force. Guidelines for the use of platelet transfusions. Br J Haematol 2003; 122:10-23.
5. Burt FJ, Swanepoel R, Shieh WJ, et al. Immunohistochemical and in situ localization of Crimean-Congo hemorrhagic fever (CCHF) virus in human tissues and implications for CCHF pathogenesis. Arch Pathol Lab Med 1997; 121:839-846. (Pubitemid 27357578)
6. Centers for Disease Control and Prevention. Management of patients with suspected viral hemorrhagic fever. MMWR Morb Mortal Wkly Rep 1988; 37(Suppl 3):1-16.
7. Cevik MA, Erbay A, Bodur H, et al. Clinical and laboratory features of Crimean-Congo hemorrhagic fever: predictors of fatality. Int J Infect Dis 2008; 12:374-379.
8. Cummins D, Bennett D, Machin SJ. Exchange transfusion of a patient with fulminant Lassa fever. Postgrad Med J 1991; 67:193-194.
9. Dalakas MC. Mechanisms of action of IVIG and therapeutic considerations in the treatment of acute and chronic demyelinating neuropathies. Neurology 2002; 59(12 Suppl 6):S13-S21. (Pubitemid 36076544)
10. Dilber E, Cakir M, Erduran E, Koksal I, et al. High-dose methylprednisolone in children with Crimean-Congo haemorrhagic fever. Trop Doct 2010; 40:27-30.
11. Geisbert TW, Jahrling PB. Exotic emerging viral diseases: progress and challenges. Nat Med 2004; 10(12 Suppl):S110-S121. (Pubitemid 40018234)
12. Grippi MA. Respiratory failure: An overview. In: Fishman's Pulmonary Diseases and Disorders, 4th ed. Fishman AP, Elias JA, Fishman JA, et al., eds. New York: McGraw-Hill 2008 2509-2521.
13. Kallen AJ, Arduino MJ, Patel PR. Preventing infections in patients undergoing hemodialysis. Expert Rev Anti Infect Ther 2010; 8:643-655.
14. Kleinman S, May AK. Indications for red cell transfusion in adults. In: UpToDate. Basow DS, ed. Waltham, MA: UpTo-Date, 2011.
15. Kurnaz F, Metan G, Coskun R, et al. A case of Crimean-Congo haemorrhagic fever successfully treated with therapeutic plasma exchange and ribavirin. Trop Doct 2011; 41:181-182.
16. Leblebicioglu H. Crimean-Congo haemorrhagic fever in Eurasia. Int J Antimicrob Agents 2010; 36(Suppl 1):S43-S46.
17. McCullough J. Overview of platelet transfusion. Semin Hematol 2010; 47:235-242.
18. McCullough J. Techniques of blood transfusion. In: Transfusion Medicine, 2 ed. McCullough J, ed. Philadelphia: Churchill Livingstone, 2005:358-379.
19. Murphy MF, Wallington TB, Kelsey P, et al. Guidelines for the clinical use of red cell transfusions. Br J Haematol 2001; 113:24-31. (Pubitemid 32423296)
20. Napolitano LM, Kurek S, Luchette FA, et al. Clinical practice guideline: red blood cell transfusion in adult trauma and critical care. J Trauma 2009; 67:1439-1442.
21. O'Shaughnessy DF, Atterbury C, Bolton MP, et al. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol 2004; 126:11-28. (Pubitemid 38859478)
22. Pannu N, Klarenbach S, Wiebe N, et al. Renal replacement therapy in patients with acute renal failure: a systematic review. JAMA 2008; 299:793-805. (Pubitemid 351281573)
23. Panpanich R, Sornchai P, Kanjanaratanakorn K. Corticosteroids for treating dengue shock syndrome. Cochrane Database Syst Rev 2006; 3:CD003488.
24. Papa A, Maltezou HC, Tsiodras S, et al. A case of Crimean-Congo haemorrhagic fever in Greece, June 2008. Euro Surveill 2008; 14:13.
25. Refaai MA, Phipps RP, Spinelli SL, et al. Platelet transfusions: impact on hemostasis, thrombosis, inflammation and clinical outcomes. Thromb Res 2011; 127:287-291.
26. Roback JD, Caldwell S, Carson J, et al. Evidence-based practice guidelines for plasma transfusion. Transfusion 2010; 50:1227-1239.
27. Schierhout G, Roberts I. Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomised trials. BMJ 1998; 316:961-964. (Pubitemid 28135143)
28. Sharma S, Sharma P, Tyler LN. Transfusion of blood and blood products: indications and complications. Am Fam Physician 2011; 83:719-724.
29. Simon CD, Perkins J, Barras P, et al. Fresh frozen plasma. U.S. Army Med Dep J 2009;64-67.
30. Spiess BD. Platelet transfusions: the science behind safety, risks and appropriate applications. Best Pract Res Clin Anaesthesiol 2010; 24:65-83.
31. Turkey Ministry of Health. (Pamphlet) May 15, 2010.
32. Uluhan R, Kilic B, Masatli R, et al. Transfuzyon pratigi. Damla Kan Merkezleri ve Transfuzyon Dernegi Bulteni 1998; 20:1-6.
33. von Heymann HC, Pruss A, Sander M, et al. Thawing procedures and the time course of clotting factor activity in freshfrozen plasma: a controlled laboratory investigation. Anesth Analg 2006; 103:969-974. (Pubitemid 44576706)
34. Whitehouse CA. Crimean-Congo hemorrhagic fever. Antiviral Res 2004; 64:145-160. (Pubitemid 39506835)
35. World Health Organization. The Clinical Use of Blood in Medicine, Obstetrics, Paediatrics, Surgery & Anaesthesia, Trauma & Burns. Geneva: Blood Transfusion Safety; 2001.
36. Xie YW, Chan PK, Szeto CK, et al. Clearance of dengue virus in the plasma-derived therapeutic proteins. Transfusion 2008; 48:1342-1347.
37. Yilmaz GR, Buzgan T, Irmak H, et al. The epidemiology of Crimean-Congo hemorrhagic fever in Turkey, 2002-2007. Int J Infect Dis 2009; 13:380-386.